Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03877003 · ClinicalTrials.gov registry record · NA
Plasma TMAO and Choline Levels in Individuals With Metabolic Syndrome - Comparison Between Eggs and Choline Supplement.
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03877003 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 25 participants.
The verdict
NCT03877003, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The objective of this study is to determine the effects of consuming either 3 eggs per day and compare it to daily choline supplement (choline bitartrate) for a dose of approximately 400 mg/day on plasma concentrations of high density lipoprotein cholesterol (HDL-c), trimethylamine N oxide (TMAO) and plasma choline. The goal is to determine if choline given as phosphatidyl choline (from eggs) will have a more beneficial effect on plasma choline and microbiota.
Interventions
- OTHER Eggs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03877003
The ClinicalTrials.gov registry entry for NCT03877003 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Eggs is the first listed.
NCT03877003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03877003 about?
NCT03877003 is a clinical study titled "Plasma TMAO and Choline Levels in Individuals With Metabolic Syndrome - Comparison Between Eggs and Choline Supplement.". The objective of this study is to determine the effects of consuming either 3 eggs per day and compare it to daily choline supplement (choline bitartrate) for a dose of approximately 400 mg/day on plasma concentrations of high density lipoprotein cholesterol (HDL-c), trimethylamine N oxide (TMAO) an...
What is the current status of trial NCT03877003?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-11-01. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03877003?
The interventions under investigation include: Eggs (OTHER).
Who is sponsoring clinical trial NCT03877003?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.